# US 2012/0083452 A1 · Topical Anesthetic Uses of Szeto-Schiller Peptides

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0083452 A1
- Document ID: US20120083452A1
- Status: Published application
- Kind: A1
- Application number: 12/895,000
- Filed: 2010-09-30
- Published: 2012-04-05
- Earliest claimed: 2010-09-30
- Inventors: Nicholas V. Perricone
- Web page: https://patentgrep.com/patent/US20120083452A1

## CPC

- A61K 38/07: Tetrapeptides
- A61K 9/0014: {Skin, i.e. galenical aspects of topical compositions (non-active ingredients are additionally classified in A61K47/00; A61K9/0009, A61K9/0021, A61K9/7015, A61K9/7023 take precedence; cosmetic preparations A61K8/00, A61Q; preparations for wound dressings or bandages A61L26/00)}
- A61K 31/137: Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine {or methadone}
- A61K 38/08: Peptides having 5 to 11 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61K 38/10: Peptides having 12 to 20 amino acids {(A61K38/043 - A61K38/046 take precedence)}
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 23/00: Anaesthetics
- A61P 23/02: Local anaesthetics
- A61P 25/00: Drugs for disorders of the nervous system
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Topical anesthetic compositions include Szeto-Schiller peptides and a dermatologically acceptable carrier, and optionally a vasoconstrictor and tyrosine. A method of providing local analgesia to the skin involves applying to skin the topical anesthetic compositions.

## Claims

### Claim 1

A topical anesthetic composition comprising:
an effective amount of at least one Szeto-Schiller peptide selected from the group consisting of: Tyr-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO: 1), Dmt-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO: 2), Phe-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO. 3) and D-Arg-Dmt-Lys-Phe-NH2 (SEQ ID. NO: 4);
a dermatologically acceptable skin-penetrating carrier;
a vasoconstrictor;
tyrosine

### Claim 2 (depends on 1)

The composition of claim 1, wherein the composition includes from about 0.0001% w/w to about 0.1% w/w peptide.

### Claim 3 (depends on 1)

The composition of claim 1, wherein the composition includes from about 0.01% w/w to about 5% w/w peptide.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the composition includes from about 100 ppm to 1000 ppm peptide.

### Claim 5 (depends on 2)

The composition of claim 2, wherein the carrier comprises lecithin.

### Claim 6 (depends on 5)

The composition of claim 5, wherein the vasoconstrictor is epinephrine.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the tyrosine is present up to 100 ppm.

### Claim 8

A topical anesthetic composition comprising: an effective amount of at least one Szeto-Schiller peptide and a dermatologically acceptable carrier.

### Claim 9 (depends on 8)

The composition of claim 8, wherein at least one peptide is selected from the group consisting of: Tyr-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO: 1), Dmt-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO: 2), Phe-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO. 3) and D-Arg-Dmt-Lys-Phe-NH2 (SEQ ID. NO: 4).

### Claim 10 (depends on 9)

The composition of claim 9 wherein the peptide is SEQ. ID. NO: 2.

### Claim 11 (depends on 8)

The composition of claim 8, wherein the composition includes from about 0.0001% w/w to about 0.1% w/w peptide.

### Claim 12 (depends on 8)

The composition of claim 8, wherein the composition includes from about 0.01% w/w to about 5% w/w peptide.

### Claim 13 (depends on 8)

The composition of claim 8, wherein the composition includes from about 100 ppm to 1000 ppm peptide.

### Claim 14 (depends on 8)

The composition of claim 8, wherein the carrier comprises lecithin.

### Claim 15 (depends on 8)

The composition of claim 8, wherein said composition further comprises a vasoconstrictor.

### Claim 16 (depends on 15)

The composition of claim 15, wherein the vasoconstrictor is epinephrine.

### Claim 17 (depends on 1)

The composition of claim 1, wherein the composition further comprises tyrosine.

### Claim 18 (depends on 17)

The composition of claim 17, wherein the tyrosine is present up to 100 ppm.

### Claim 19

A method of providing local analgesia to the skin comprising: applying to the skin tissue of a mammal in need of such regulation, a safe and effective amount of a composition comprising at least one Szeto-Schiller peptide and a dermatologically acceptable carrier.

### Claim 20 (depends on 19)

The method of claim 19 wherein the peptide is selected from the group consisting of: Tyr-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO: 1), Dmt-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO: 2), Phe-D-Arg-Phe-Lys-NH2 (SEQ. ID. NO. 3) and D-Arg-Dmt-Lys-Phe-NH2 (SEQ ID. NO: 4).

### Claim 21 (depends on 20)

The method of claim 20, wherein the peptide is SEQ. ID. NO: 2.

### Claim 22

A method of treating skin pain comprising: applying to the skin tissue of a mammal in need of such regulation, a safe and effective amount of a composition comprising at least one Szeto-Schiller peptide and a dermatologically acceptable carrier.

### Claim 23

A method of treating skin itching comprising: applying to the skin tissue of a mammal in need of such regulation, a safe and effective amount of a composition comprising at least one Szeto-Schiller peptide and a dermatologically acceptable carrier.

### Claim 24

A method of preparing skin for medical procedures comprising: applying to the skin tissue of a mammal in need of such regulation, a safe and effective amount of a composition comprising at least one Szeto-Schiller peptide and a dermatologically acceptable carrier.
